Share the post "Novartis India Limited. : .Q4 .2024 .Quarterly Earnings: .YoY Sales Up .6.62. %, QoQ Down 3.99 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 6.62 % in the past year, decrease in net sales/revenue by -3.99 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -36.35 %, Marginal decrease of -52.55% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Novartis India Limited.. Profit dropped by -41.33 % Year to Year, Novartis India Limited.’s profitability dropped by -44.75 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -41.26 % Year to Year. EPS decreased by -44.7 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 76.13 Cr | Rs. 84.54 Cr | Rs. 81.17 Cr | -3.99 % | + 6.62 % |
| Expenses | Rs. 66.81 Cr | Rs. 64.77 Cr | Rs. 69.96 Cr | + 8.01 % | + 4.71 % |
| Operating Profit | Rs. 9.32 Cr | Rs. 19.77 Cr | Rs. 11.21 Cr | -43.3 % | + 20.28 % |
| OPM % | 12.24 % | 23.39 % | 13.81 % | -9.58 % | + 1.57 % |
| Other Income | Rs. 16.37 Cr | Rs. 21.96 Cr | Rs. 10.42 Cr | -52.55 % | -36.35 % |
| Interest | Rs. 0.3 Cr | Rs. 0.16 Cr | Rs. 0.16 Cr | + 0 % | -46.67 % |
| Depreciation | Rs. 2.08 Cr | Rs. 0.26 Cr | Rs. 0.14 Cr | -46.15 % | -93.27 % |
| Profit before tax | Rs. 23.31 Cr | Rs. 41.31 Cr | Rs. 21.33 Cr | -48.37 % | -8.49 % |
| Tax % | 7.34 % | 35.68 % | 31.18 % | -4.5 % | + 23.84 % |
| Net Profit | Rs. 25.02 Cr | Rs. 26.57 Cr | Rs. 14.68 Cr | -44.75 % | -41.33 % |
| EPS in Rs | Rs. 10.13 | Rs. 10.76 | Rs. 5.95 | -44.7 % | -41.26 % |
Today, we’re looking at Novartis India Limited.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 6.62 %. However, it did see a marginal slip of -3.99 % from the previous quarter. Expenses ticked up slightly by 8.01 % quarter-on-quarter, aligning with the annual rise of 4.71 %. Operating profit, while up 20.28 % compared to last year, faced a quarter-on-quarter dip of -43.3 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.57 %, but a shrinkage of -9.58 % sequentially. Other income fell by -52.55 % compared to the last quarter, despite an annual decline of -36.35 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year decrease remains at a moderate -46.67 %. Depreciation costs fell by -46.15 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -93.27 %. Profit before tax declined annually by -8.49 % but saw a reduction from the preceding quarter by -48.37 %.
Tax expenses as a percentage of profits increased slightly by 23.84 % compared to last year, with a more notable quarter-on-quarter decrease of -4.5 %. Net profit fell by -41.33 % year-on-year but witnessed a -44.75 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -41.26 % but a quarterly fall of -44.7 %. In summary, Novartis India Limited.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 76.13 Cr | Rs. 84.54 Cr | Rs. 81.17 Cr | -3.99 % | + 6.62 % |
| Expenses | Rs. 66.81 Cr | Rs. 64.77 Cr | Rs. 69.96 Cr | + 8.01 % | + 4.71 % |
| Operating Profit | Rs. 9.32 Cr | Rs. 19.77 Cr | Rs. 11.21 Cr | -43.3 % | + 20.28 % |
| Net Profit | Rs. 25.02 Cr | Rs. 26.57 Cr | Rs. 14.68 Cr | -44.75 % | -41.33 % |
| EPS in Rs | Rs. 10.13 | Rs. 10.76 | Rs. 5.95 | -44.7 % | -41.26 % |
In reviewing Novartis India Limited.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 6.62 % year-on-year growth, although there was a slight dip of -3.99 % from the previous quarter. Expenses rose by 4.71 % compared to the previous year, with a 8.01 % increase quarter-on-quarter. Operating Profit surged by 20.28 % annually, and saw a -43.3 % decrease from the last quarter.
Net Profit showed yearly decrease of -41.33 %, and experienced a -44.75 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -41.26 % annually, however dipped by -44.7 % compared to the last quarter. In essence, while Novartis India Limited. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
